Sonoma Pharmaceuticals (SNOA) Other financing activities (2012 - 2020)

Sonoma Pharmaceuticals' Other financing activities history runs 9 years deep, the most recent figure standing at $90000.0 for Q4 2020.

• In Q4 2020, Other financing activities rose 114.29% year-over-year to $90000.0; the TTM figure through Dec 2020 stood at $52000.0 (down 7.14% YoY), while the FY2020 annual figure was $50000.0, up 261.29% from the prior year.
• Other financing activities was $90000.0 for Q4 2020 at Sonoma Pharmaceuticals, up from -$34000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $90000.0 in Q4 2020 to a low of -$50000.0 in Q3 2018.
• Historically, Other financing activities has averaged $2800.0 across 5 years, with a median of $2000.0 in 2016.
• The sharpest annual moves came in 2016 and 2019: Other financing activities sank 650.0% in 2016, then soared 4100.0% in 2019.
• A 5-year view of Other financing activities shows it stood at -$22000.0 in 2016, then surged by 95.45% to -$1000.0 in 2017, then soared by 200.0% to $1000.0 in 2018, then jumped by 4100.0% to $42000.0 in 2019, then soared by 114.29% to $90000.0 in 2020.
• The last three Other financing activities figures came in at $90000.0 (Q4 2020), -$34000.0 (Q3 2020), and -$4000.0 (Q2 2020), per Business Quant data.